Virpax’s(R) MMS019 Inhibits SARS-COV-2 in Ex-Vivo Airway Model
NASDAQ: VRPX
Corporate Headquarters
1055 Westlakes Drive, Suite 300
Berwyn, PA 19312
Phone 610.727.4597
Email info@virpaxpharma.com
NASDAQ: VRPX
Corporate Headquarters
1055 Westlakes Drive, Suite 300
Berwyn, PA 19312
Phone 610.727.4597
Email info@virpaxpharma.com
© Virpax® Pharmaceuticals. All Rights Reserved.
© Virpax® Pharmaceuticals. All Rights Reserved.
